<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id><journal-id journal-id-type="iso-abbrev">Arq. Bras. Cardiol</journal-id><journal-id journal-id-type="publisher-id">Arq. Bras. Cardiol.</journal-id><journal-title-group><journal-title>Arquivos Brasileiros de Cardiologia</journal-title></journal-title-group><issn pub-type="ppub">0066-782X</issn><issn pub-type="epub">1678-4170</issn><publisher><publisher-name>Sociedade Brasileira de Cardiologia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24652053</article-id><article-id pub-id-type="pmc">4028945</article-id><article-id pub-id-type="doi">10.5935/abc.20140029</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Alimentary Habits, Physical Activity, and Framingham Global Risk
Score in Metabolic Syndrome</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Soares</surname><given-names>Thays Soliman</given-names></name></contrib><contrib contrib-type="author"><name><surname>Piovesan</surname><given-names>Carla Haas</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gustavo</surname><given-names>Andr&#x000e9;ia da Silva</given-names></name></contrib><contrib contrib-type="author"><name><surname>Macagnan</surname><given-names>Fabr&#x000ed;cio Edler</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bodanese</surname><given-names>Luiz Carlos</given-names></name></contrib><contrib contrib-type="author"><name><surname>Feoli</surname><given-names>Ana Maria Pandolfo</given-names></name><xref ref-type="corresp" rid="c01"/></contrib><aff> Pontif&#x000ed;cia Universidade Cat&#x000f3;lica do Rio Grande do Sul (PUCRS), Porto Alegre,
RS - Brazil</aff></contrib-group><author-notes><corresp id="c01"><bold>Mailing Address: Ana Maria Pandolfo Feoli</bold>, Faculdade de Enfermagem,
Nutri&#x000e7;&#x000e3;o e Fisioterapia da Pontif&#x000ed;cia Universidade Cat&#x000f3;lica do Rio grande do
Sul. Avenida Ipiranga, 6.681, pr&#x000e9;dio 12. Postal Code 90619-900, Porto Alegre, RS
- Brazil. E-mail: <email>anamariafeoli@hotmail.com</email>.</corresp></author-notes><pub-date pub-type="ppub"><month>4</month><year>2014</year></pub-date><volume>102</volume><issue>4</issue><fpage>374</fpage><lpage>382</lpage><history><date date-type="received"><day>23</day><month>1</month><year>2013</year></date><date date-type="rev-recd"><day>04</day><month>11</month><year>2013</year></date><date date-type="accepted"><day>06</day><month>11</month><year>2013</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium, provided the original work is properly cited. </license-p></license></permissions><abstract><sec><title>Background</title><p>Metabolic syndrome is a complex disorder represented by a set of
cardiovascular risk factors. A healthy lifestyle is strongly related to
improve Quality of Life and interfere positively in the control of risk
factors presented in this condition. </p></sec><sec><title>Objective</title><p>To evaluate the effect of a program of lifestyle modification on the
Framingham General Cardiovascular Risk Profile in subjects diagnosed with
metabolic syndrome. </p></sec><sec><title>Methods</title><p>A sub-analysis study of a randomized clinical trial controlled blind that
lasted three months. Participants were randomized into four groups: dietary
intervention + placebo (DIP), dietary intervention + supplementation of
omega 3 (fish oil 3 g/day) (DIS3), dietary intervention + placebo + physical
activity (DIPE) and dietary intervention + physical activity +
supplementation of omega 3 (DIS3PE). The general cardiovascular risk profile
of each individual was calculated before and after the intervention. </p></sec><sec><title>Results</title><p>The study included 70 subjects. Evaluating the score between the pre and post
intervention yielded a significant value (p &#x0003c; 0.001). We obtained a
reduction for intermediate risk in 25.7% of subjects. After intervention,
there was a significant reduction (p &#x0003c; 0.01) on cardiovascular age, this
being more significant in groups DIP (5.2%) and DIPE (5.3%). </p></sec><sec><title>Conclusion</title><p>Proposed interventions produced beneficial effects for reducing
cardiovascular risk score. This study emphasizes the importance of lifestyle
modification in the prevention and treatment of cardiovascular diseases.</p></sec></abstract><kwd-group><kwd>Food habits</kwd><kwd>Cardiovascular diseases</kwd><kwd>Lifestyle</kwd><kwd>Exercise</kwd><kwd>Probability</kwd><kwd>Risk factors</kwd><kwd>Metabolic x Syndrome</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Metabolic syndrome (MS) is a clinical condition described as a group of metabolic
disorders and cardiovascular risk factors, which are generally associated with
central fat deposition and insulin resistance, present in the same
individual<sup><xref rid="r01" ref-type="bibr">1</xref></sup>.According to
the World Health Organization (WHO), cardiovascular diseases accounted for 33%
deaths in Brazil in 2011<sup><xref rid="r02" ref-type="bibr">2</xref></sup>, a
relevant fact when associated with the estimate that MS is responsible for a
2.5-times increase in cardiovascular mortality<sup><xref rid="r01" ref-type="bibr">1</xref></sup>. </p><p>Structured lifestyle modification programs, including dietary education and
supervised physical exercise, are effective for the treatment of MS. The use of fish
oil, which is rich in omega 3 fatty acids, helps in decreasing plasma triglycerides,
very low-density lipoprotein (VLDL), and arterial pressure, and it is recommended
for the treatment of MS in association with lifestyle intervention<sup><xref rid="r03" ref-type="bibr">3</xref>-<xref rid="r06" ref-type="bibr">6</xref></sup>.</p><p>Scores that allow the stratification of the risk for cardiovascular disease, such as
the Framinghan score, have been used to identify individuals at a higher risk for
cardiovascular events and are indicators of the potential benefits of lifestyle
changes and pharmacological treatment<sup><xref rid="r07" ref-type="bibr">7</xref>-<xref rid="r09" ref-type="bibr">9</xref></sup>.</p><p>In Brazil, the Ministry of Health recommends the use of Framingham scores as a
strategy to estimate cardiovascular risk. The use of scores that allow the
stratification of risk is important in the primary prevention of cardiovascular
disease, in view of the multiplicity of risk factors that an individual may
present<sup><xref rid="r10" ref-type="bibr">10</xref></sup>.</p><p>The overall cardiovascular risk score, which was recently published by the Framingham
study group, now includes the risk for future overall cardiovascular events, i.e.,
stroke, transient ischemic attack, and heart failure. In addition, this new score
includes the concept of vascular age (VA), which aims to adjust the age of patients
according to their atherosclerotic state<sup><xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref></sup>.</p><p>This study aimed to determine the effects of a lifestyle modification program on the
Framingham risk score in individuals with MS.</p></sec><sec sec-type="methods"><title>Methods</title><p>This was a blinded, randomized, controlled clinical trial that aimed to study the
effects of distinct lifestyle change interventions on the Framingham risk score and
cardiovascular risk factors for MS.</p><p>The study sample was extracted from a secondary database of a primary study in which
the participants were selected from a group of volunteers who enrolled after the
study was announced in the press or promoted by the cardiology outpatient clinic of
the Hospital S&#x000e3;o Lucas at the Pontif&#x000ed;cia Universidade Cat&#x000f3;lica of Rio Grande do Sul
(PUC-RS). The participants included men and women aged between 30 and 60 years who
exhibited three or more of the findings indicated by the National Cholesterol
Education Program Adult Treatment Panel III (NCEP-ATP III)<sup><xref rid="r08" ref-type="bibr">8</xref>,<xref rid="r13" ref-type="bibr">13</xref></sup>: an
abdominal circumference (AC) of &#x0003e; 88 cm for women and &#x0003e; 102 cm for men, a
systolic arterial pressure (SAP) of &#x02265; 130 mmHg and a diastolic arterial pressure of
&#x02265; 85 mmHg, a fasting glucose level of &#x02265; 100 mg/dL, a triglyceride level of &#x02265;150
mg/dL, and a high-density lipoprotein cholesterol (HDL-C) level of &#x0003c; 40 mg/dL for
men and &#x0003c; 50 mg/dL for women. Patients with absolute contraindications for
physical activity because of musculoskeletal, neurological, vascular, pulmonary, and
cardiac problems; those on lipid-lowering medication; those on anticoagulant
medication; those who exercised regularly (30 min twice a week or more); those with
a psychiatric disorder; those on antidepressant medication; those diagnosed
hypothyroidism; pregnant patients; those consuming omega 3 supplements or any other
food or vitamin supplements; and those who were difficult to contact and/or were
lost to follow-up were excluded.</p><p>A total of 87 individuals were eligible for the study. All patients were provided
with information about the study through the informed consent document.</p><p>After the initial evaluation, the patients were randomized into 4 groups that
received one of the following interventions over 3 months: (1) dietary intervention
(DI) and placebo administration (1 g/day of mineral oil; DIP), (2) DI combined with
omega 3 fatty acid (1 g/day) supplementation (DIS3), (3) DI and placebo
administration (1 g/day of mineral oil) combined with a physical exercise program (3
times per week) (DIPE), and (4) DI and omega 3 supplementation (1 g/day) combined
with a physical exercise program (3 times per week; DIS3PE). The scheme of the study
is shown in <xref ref-type="fig" rid="f01">Figure 1</xref>.</p><fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Study scheme.</p><p>DIP: dietary intervention; DIPE: dietary intervention + physical activity;
DIS3: dietary intervention + omega 3 fatty acid supplementation; DIS3PE:
dietary intervention + physical activity + omega 3 fatty acid
supplementation.</p></caption><graphic xlink:href="abc-102-04-0374-g01"/></fig><p>DI was supervised by the nutrition team, while the physical exercise sessions were
supervised by the physiotherapy team; both teams comprised fully trained
professionals. The biochemical tests were performed using blood samples collected
via venipuncture after 12 h of fasting. Plasma glucose, total cholesterol (TC),
serum triglyceride, and serum HDL-C levels were determined through enzymatic methods
performed in a fully automated analyzer (VITROS 950 dry-chemistry system, Johnson
&#x00026; Johnson, Rochester, NY, USA). Low-density lipoprotein cholesterol (LDL-C)
levels were estimated using the Friedewald equation<sup><xref rid="r14" ref-type="bibr">14</xref></sup>.</p><p>The dietary follow-up included two assessments, one at the start of the intervention
and the second at the end of the follow up period, as well as fortnightly
consultations. The assessments included the following: anamnesis of eating habits, a
24-h record of food intake, a 2-day record of food intake, and anthropometric
evaluation. In each consultation, a 24-h record of food intake was assessed to
monitor diet adherence. In addition, targets for the following consultation were
set; weight and AC were measured; healthy eating topics such as food labels, trans
fats, functional foods, food pyramid, sodium intake, and five-a-day program were
discussed; and doubts were clarified. At each consultation, the correct use of
capsules was checked and the DIP and DIS3 groups were instructed to provide a brief
report on the adherence to physical exercise.</p><p>The anthropometric evaluation included the measurement of body weight, height, and
AC. Body weight was measured using a calibrated Cauduro&#x000ae; scale with a maximum
capacity of 160 kg; the patients were barefoot and wore light clothes during
measurement. Height was measured using a vertical millimeter stadiometer, with a
maximum extension of 2 m and a scale of 0.5 cm attached to the scales. The AC was
measured in the abdominal region where there is maximum extension, as recommended by
Lohman et al<sup><xref rid="r15" ref-type="bibr">15</xref></sup>, using a common
150-cm inextensible and inelastic tape measure.</p><p>The dietary intervention included an eating plan, which was given to the patients
during the first consultation. The eating plan was based on the recommendations of
the First Brazilian Guideline for the Diagnosis and Treatment of Metabolic Syndrome
(I DBSM)<sup><xref rid="r01" ref-type="bibr">1</xref></sup>, which recommends the
following composition: total calories, to reduce weight by 5% to 10%; carbohydrates,
50% to 60% of total calories, with an emphasis on complex carbohydrates; fibers, 20
to 30 g/day; total fat, 25% to 35% of total calories; saturated fatty acids, &#x0003c;
10% of total calories; polyunsaturated fatty acids, up to 10% of total calories;
monounsaturated fatty acids, up to 20% of total calories; cholesterol, &#x0003c; 300
mg/day; proteins, 0.8 g to 1.0 g/kg current weight/day or 15% of total calories;
micronutrients, in accordance with the recommendations of the Dietary Reference
Intakes (DRIs)<sup><xref rid="r16" ref-type="bibr">16</xref></sup>, with an emphasis
on antioxidants.</p><p>There were a total of 36 physical exercise sessions, including walking on a treadmill
for 30 min 3 times a week. Speed and inclination were maintained within a range of
65%-75% of the maximum heart rate according to the patient's age<sup><xref rid="r01" ref-type="bibr">1</xref></sup>.</p><p>Analysis of the overall cardiovascular risk score (OCRS) estimate included the
following factors: age, gender, TC levels, HDL-C levels, SAP, smoking history, use
of antihypertensive medication, and diabetes mellitus. A calculator available on the
study website, which was based on the lipid profile, was used to calculate the risk
score and VA for each individual<sup><xref rid="r17" ref-type="bibr">17</xref></sup>. The stratification of the score for assessing the overall
cardiovascular risk profile over 10 years is as follows: low risk, &#x0003c;6%;
intermediate risk, between 6% and 20%; and high risk, &#x0003e;20%<sup><xref rid="r11" ref-type="bibr">11</xref></sup>.</p><p>Descriptive statistics were used to analyze the data, namely frequency distribution
and relative frequency distribution, mean, and standard deviation. The
Kolmogorov-Smirnov test was used to study the symmetry of data distribution. To
compare the continuous variables between the initial and final moments as well as
between groups, analysis of variance (ANOVA) was used for repeated measurements,
with measurements relating to the intragroup factor and intervention as an
intergroup factor. The Bonferroni test was used for <italic>post-hoc
</italic>analysis (p &#x0003c; 0.05).</p><p>The baseline characteristics of patients were compared using one-way analysis of
variance (one-way ANOVA) followed by <italic>post-hoc</italic> Bonferroni and
Kruskal-Wallis tests, which were followed by <italic>post-hoc</italic> Dunn's test.
Data were analyzed using the Statistical Package for the Social Sciences (SPSS)
software, 20.0<sup><xref rid="r13" ref-type="bibr">13</xref></sup>. The level of
significance (&#x003b1;) was set at 5%.</p><p>Confidentiality and professional secrecy criteria related to the information
collected during the study were met according to resolution 196/96, which
establishes the guidelines for research in human beings. The study was approved by
the Research Ethics Committee of the PUC-RS under process 0603024.</p></sec><sec sec-type="results"><title>Results</title><p>Of the 87 eligible individuals, 17 discontinued their participation in the study
because of travelling difficulties, personal situation, or inability to perform
physical exercise. Eventually, 70 patients participated. Of these, 71.4% were women.
The mean age of patients was 51.4 &#x000b1; 6.52 years. The distribution of patients in each
group was as follows: DIP, 25.7%, n = 18; DIS3, 28.6%, n = 20; DIPE, 21.4%, n = 15;
and DIS3PE, 24.3%, n = 17).</p><p>Before the intervention, there was no significant difference between the groups with
regard to the variables under analysis; the group as a whole was thus homogeneous
(<xref ref-type="table" rid="t01">Table 1</xref>).</p><table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><p>Characteristics of the sample</p></caption><table frame="hsides" rules="rows"><thead><tr><th align="left" rowspan="1" colspan="1"><bold>Characteristics</bold></th><th rowspan="1" colspan="1"><bold>DIP</bold></th><th rowspan="1" colspan="1"><bold>DIPE</bold></th><th rowspan="1" colspan="1"><bold>DIS3</bold></th><th rowspan="1" colspan="1"><bold>DIS3PE</bold></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age#</td><td align="center" rowspan="1" colspan="1">51.6 &#x000b1; 13.4</td><td align="center" rowspan="1" colspan="1">50.8 &#x000b1; 13.7</td><td align="center" rowspan="1" colspan="1">52 &#x000b1; 12.5</td><td align="center" rowspan="1" colspan="1">51 &#x000b1; 14.7</td></tr><tr><td rowspan="1" colspan="1">Weight#</td><td align="center" rowspan="1" colspan="1">81.6 &#x000b1; 21.5</td><td align="center" rowspan="1" colspan="1">84.7 &#x000b1; 23.6</td><td align="center" rowspan="1" colspan="1">88.78 &#x000b1; 22.7</td><td align="center" rowspan="1" colspan="1">90.3 &#x000b1; 24.9</td></tr><tr><td rowspan="1" colspan="1">Height#</td><td align="center" rowspan="1" colspan="1">1.60 &#x000b1; 0.1</td><td align="center" rowspan="1" colspan="1">1.60 &#x000b1; 0.2</td><td align="center" rowspan="1" colspan="1">1.61 &#x000b1; 0.2</td><td align="center" rowspan="1" colspan="1">1.60 &#x000b1; 0.2</td></tr><tr><td rowspan="1" colspan="1">BMI#</td><td align="center" rowspan="1" colspan="1">32.8 &#x000b1; 8.1</td><td align="center" rowspan="1" colspan="1">32.3 &#x000b1; 8.9</td><td align="center" rowspan="1" colspan="1">34.1 &#x000b1; 7.9</td><td align="center" rowspan="1" colspan="1">33.5 &#x000b1; 8.6</td></tr><tr><td rowspan="1" colspan="1">AC#</td><td align="center" rowspan="1" colspan="1">104.0 &#x000b1; 24.7</td><td align="center" rowspan="1" colspan="1">102.2 &#x000b1; 26.4</td><td align="center" rowspan="1" colspan="1">109.9 &#x000b1; 25.3</td><td align="center" rowspan="1" colspan="1">108.1 &#x000b1; 27.2</td></tr><tr><td rowspan="1" colspan="1">TG&#x000b6;</td><td align="center" rowspan="1" colspan="1">199.6 &#x000b1; 126.3</td><td align="center" rowspan="1" colspan="1">194.5 &#x000b1; 96.3</td><td align="center" rowspan="1" colspan="1">193.8 &#x000b1; 93.2</td><td align="center" rowspan="1" colspan="1">198.6 &#x000b1; 76.3</td></tr><tr><td rowspan="1" colspan="1">HDL&#x000b6;</td><td align="center" rowspan="1" colspan="1">47.3 &#x000b1; 14.1</td><td align="center" rowspan="1" colspan="1">45.7 &#x000b1; 15.7</td><td align="center" rowspan="1" colspan="1">44.65 &#x000b1; 14.9</td><td align="center" rowspan="1" colspan="1">40.8 &#x000b1; 12.3</td></tr><tr><td rowspan="1" colspan="1">Glucose</td><td align="center" rowspan="1" colspan="1">95.1 &#x000b1; 23.1</td><td align="center" rowspan="1" colspan="1">112.9 &#x000b1; 69.0</td><td align="center" rowspan="1" colspan="1">111.75 &#x000b1; 41.4</td><td align="center" rowspan="1" colspan="1">110.1 &#x000b1; 33.3</td></tr><tr><td rowspan="1" colspan="1">SAP#</td><td align="center" rowspan="1" colspan="1">134.4 &#x000b1; 35.1</td><td align="center" rowspan="1" colspan="1">131.1 &#x000b1; 36.6</td><td align="center" rowspan="1" colspan="1">130.2 &#x000b1; 31.7</td><td align="center" rowspan="1" colspan="1">131.6 &#x000b1; 36.3</td></tr><tr><td rowspan="1" colspan="1">DAP#</td><td align="center" rowspan="1" colspan="1">85.3 &#x000b1; 21.2</td><td align="center" rowspan="1" colspan="1">84.3 &#x000b1; 22.4</td><td align="center" rowspan="1" colspan="1">83.9 &#x000b1; 23.1</td><td align="center" rowspan="1" colspan="1">78.2 &#x000b1; 20.3</td></tr></tbody></table><table-wrap-foot><fn><p># One-way analysis of variance (One-way ANOVA) - Bonferroni test
(post-hoc); &#x000b6; Kruskal-Wallis test (post-hoc Dunn's). DIP: dietary
intervention; DIPE: dietary intervention + physical activity; DIS3:
dietary intervention + omega 3 fatty acid supplementation; DIS3PE:
dietary intervention + physical activity + omega 3 fatty acid
supplementation; BMI: body mass index; AC: abdominal circumference; TG:
triglycerides; HDL: high-density lipoprotein; SAP: systolic arterial
pressure; DAP: diastolic arterial pressure.</p></fn></table-wrap-foot></table-wrap><p>The mean OCRS was lower after the intervention than before the intervention in all
groups; these scores were between 9.7% (DIPE group) and 21.6% (DIP group), and the
difference was significant (p &#x0003c; 0.05) in the DIP and DIS3PE groups. The mean
score before and after the intervention was not significantly different among groups
(p &#x0003e; 0.05).</p><p>Repeated measurement analysis revealed that the effect of time was significant (p
&#x0003c; 0,001). Regardless of group, the mean values were lower after the intervention.
Considering only the group effect, the differences observed were not significant (p
&#x0003e; 0.05), i.e., the mean OCRS in all groups were statistically similar at the
beginning and end of the study (<xref ref-type="table" rid="t02">Table
2</xref>).</p><table-wrap id="t02" orientation="portrait" position="float"><label>Table 2</label><caption><p>Mean and standard deviation for the overall risk score (OCRS) and vascular
age (VA) before and after the intervention for each group</p></caption><table frame="hsides" rules="rows"><thead><tr align="center"><th rowspan="3" align="left" colspan="1"><bold>Variables</bold></th><th colspan="4" rowspan="1"><bold>Bivariate</bold></th><th rowspan="1" colspan="1">&#x000a0;</th><th colspan="3" rowspan="1"><bold>Multivariate</bold></th></tr><tr><th colspan="4" align="center" rowspan="1"><bold>Groups</bold></th><th rowspan="2" align="center" colspan="1"><bold>p between
groups</bold></th><th rowspan="2" align="center" colspan="1"><bold>p time effect//</bold></th><th rowspan="2" align="center" colspan="1"><bold>p group effect&#x000b6;</bold></th><th rowspan="2" align="center" colspan="1"><bold>p Interaction
effect#</bold></th></tr><tr><th align="center" rowspan="1" colspan="1"><bold>DIP(n = 18)</bold></th><th align="center" rowspan="1" colspan="1"><bold>DIPE (n = 15)</bold></th><th align="center" rowspan="1" colspan="1"><bold>DIS3 (n = 20)</bold></th><th align="center" rowspan="1" colspan="1"><bold>DIS3PE (n = 17)</bold></th></tr></thead><tbody><tr><td colspan="9" rowspan="1"><bold>OCRS</bold></td></tr><tr><td rowspan="1" colspan="1">Before</td><td align="center" rowspan="1" colspan="1">13.4 &#x000b1; 2.3</td><td align="center" rowspan="1" colspan="1">12.4 &#x000b1; 2.1</td><td align="center" rowspan="1" colspan="1">13.3 &#x000b1; 1.8</td><td align="center" rowspan="1" colspan="1">14.3 &#x000b1; 2.1</td><td align="center" rowspan="1" colspan="1">0.784&#x02021;</td><td rowspan="2" align="center" colspan="1">0.001</td><td rowspan="2" align="center" colspan="1">0,957</td><td rowspan="2" align="center" colspan="1">0,770</td></tr><tr><td rowspan="1" colspan="1">After</td><td align="center" rowspan="1" colspan="1">10.5 &#x000b1; 1.7</td><td align="center" rowspan="1" colspan="1">11.2 &#x000b1; 2.3</td><td align="center" rowspan="1" colspan="1">11.4 &#x000b1; 1.5</td><td align="center" rowspan="1" colspan="1">11.9 &#x000b1; 1,8</td><td align="center" rowspan="1" colspan="1">0.881&#x000a7;</td></tr><tr><td rowspan="1" colspan="1">p intra&#x02020;</td><td align="center" rowspan="1" colspan="1">0.034</td><td align="center" rowspan="1" colspan="1">0.427</td><td align="center" rowspan="1" colspan="1">0.082</td><td align="center" rowspan="1" colspan="1">0,029</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x00394;OCRS</td><td align="center" rowspan="1" colspan="1">2.9</td><td align="center" rowspan="1" colspan="1">1.2</td><td align="center" rowspan="1" colspan="1">1.9</td><td align="center" rowspan="1" colspan="1">2.4</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">% &#x00394;OCRS</td><td align="center" rowspan="1" colspan="1">21.6</td><td align="center" rowspan="1" colspan="1">9.7</td><td align="center" rowspan="1" colspan="1">14.3</td><td align="center" rowspan="1" colspan="1">16.8</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td colspan="9" rowspan="1"><bold>VA</bold></td></tr><tr><td rowspan="1" colspan="1">Before</td><td align="center" rowspan="1" colspan="1">67.9 &#x000b1; 3.4</td><td align="center" rowspan="1" colspan="1">67.6 &#x000b1; 3.3</td><td align="center" rowspan="1" colspan="1">68.1 &#x000b1; 3.4</td><td align="center" rowspan="1" colspan="1">69.5 &#x000b1; 4.1</td><td align="center" rowspan="1" colspan="1">0.802&#x02021;</td><td rowspan="2" align="center" colspan="1">0.003</td><td rowspan="2" align="center" colspan="1">0.962</td><td rowspan="2" align="center" colspan="1">0.966</td></tr><tr><td rowspan="1" colspan="1">After</td><td align="center" rowspan="1" colspan="1">64.4 &#x000b1; 3.4</td><td align="center" rowspan="1" colspan="1">64.0 &#x000b1; 3.9</td><td align="center" rowspan="1" colspan="1">65.6 &#x000b1; 3.2</td><td align="center" rowspan="1" colspan="1">66.9 &#x000b1; 4.1</td><td align="center" rowspan="1" colspan="1">0.772&#x000a7;</td></tr><tr><td rowspan="1" colspan="1">p intra&#x02020;</td><td align="center" rowspan="1" colspan="1">0.151</td><td align="center" rowspan="1" colspan="1">0.055</td><td align="center" rowspan="1" colspan="1">0.199</td><td align="center" rowspan="1" colspan="1">0.183</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x00394;VA</td><td align="center" rowspan="1" colspan="1">3.5</td><td align="center" rowspan="1" colspan="1">3.6</td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">2.6</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">% &#x00394;VA</td><td align="center" rowspan="1" colspan="1">5.2</td><td align="center" rowspan="1" colspan="1">5.3</td><td align="center" rowspan="1" colspan="1">3.7</td><td align="center" rowspan="1" colspan="1">3.9</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn><p>//: time effect (before versus after); &#x000b6;: group effects; #: effects of
interaction time versus group; &#x02021;: comparison among groups before the
intervention; &#x000a7;: comparison among groups after the intervention; &#x02020;.
comparison before and after the intervention; &#x00394;: mean variation
(initial - initial). DIP: dietary intervention; DIPE: dietary
intervention + physical activity; DIS3: dietary intervention + omega 3
fatty acid supplementation; DIS3PE: dietary intervention + physical
activity + omega 3 fatty acid supplementation.</p></fn></table-wrap-foot></table-wrap><p>The mean VA was higher than the chronological age of all the volunteers in all
groups. The effect of time was significant (p &#x0003c; 0.01), indicating a decrease in
the mean score after the intervention. At the end of treatment, all groups exhibited
a lower mean VA. On comparing the pre and post-intervention evaluations, the
greatest decrease in VA was observed in the DIPE (5.3%) and DIP (5.2%) groups. All
groups exhibited the same behavior pattern (p &#x0003e; 0.05) and did not differ among
themselves. In addition, they did not differ with regard to their responses over
time (p &#x0003e; 0.05; <xref ref-type="table" rid="t02">Table 2</xref>).</p><p>Before the intervention, the individuals were classified in the following risk
categories: 24.3% were at low risk, 50% were at intermediate risk, and 25.7% were at
high risk. After the intervention, 14.3% patients at high risk exhibited a decrease
in their scores and fell into the intermediate-risk group, i.e., the prevalence of
individuals at high risk decreased to 11.4%, while that of individuals at
intermediate risk increased to 64.3%. </p><p>To analyze the risk factors associated with MS that are included in the calculation
of the OCRS, it was necessary to stratify the AC and HDL-C levels according to
gender because the cut-off values are different. </p><p>The TC levels varied significantly with time (p &#x0003c; 0.05). However, the mean scores
for the groups before and after the intervention did not follow a pattern. The DIP,
DIPE, and DIS3 groups exhibited a decrease in TC levels after the intervention,
whereas the DIS3PE group exhibited an increase. However, all groups exhibited the
same pattern of behavior in regard to the group effect (p &#x0003e; 0,05) and interaction
(p &#x0003e; 0.05), indicating that the treatments and responses did not differ over time
(<xref ref-type="table" rid="t03">Table 3</xref>).</p><table-wrap id="t03" orientation="portrait" position="float"><label>Table 3</label><caption><p>Mean and standard deviation for total cholesterol (TC) and high-density
lipoprotein cholestrol (HDL-C) levels before and after the intervention for
each group</p></caption><table frame="hsides" rules="rows"><thead><tr><th rowspan="3" align="left" colspan="1"><bold>Variables</bold></th><th colspan="4" align="center" rowspan="1"><bold>Bivariate</bold></th><th colspan="4" align="center" rowspan="1"><bold>Multivariate</bold></th></tr><tr><th colspan="4" rowspan="1"><bold>Groups</bold></th><th rowspan="2" colspan="1"><bold>p between groups</bold></th><th rowspan="2" colspan="1"><bold>p time effect//</bold></th><th rowspan="2" colspan="1"><bold>p group effect&#x000b6;</bold></th><th rowspan="2" colspan="1"><bold>p interactioneffect#</bold></th></tr><tr><th rowspan="1" colspan="1"><bold>DIP (n = 18)</bold></th><th rowspan="1" colspan="1"><bold>DIPE (n = 15)</bold></th><th rowspan="1" colspan="1"><bold>DIS3 (n = 20)</bold></th><th rowspan="1" colspan="1"><bold>DIS3PE (n = 17)</bold></th></tr></thead><tbody><tr><td colspan="9" rowspan="1"><bold>TC</bold></td></tr><tr><td rowspan="1" colspan="1">Before</td><td align="center" rowspan="1" colspan="1">233.9 &#x000b1; 12.3</td><td align="center" rowspan="1" colspan="1">227.5 &#x000b1; 13.6</td><td align="center" rowspan="1" colspan="1">223.8 &#x000b1; 11,7</td><td align="center" rowspan="1" colspan="1">213.1 &#x000b1; 12.7</td><td align="center" rowspan="1" colspan="1">0.064&#x02021;</td><td rowspan="2" align="center" colspan="1">0.032</td><td rowspan="2" align="center" colspan="1">0.995</td><td rowspan="2" align="center" colspan="1">0.130</td></tr><tr><td rowspan="1" colspan="1">After</td><td align="center" rowspan="1" colspan="1">203.9 &#x000b1; 11.4</td><td align="center" rowspan="1" colspan="1">212.2 &#x000b1; 12.5</td><td align="center" rowspan="1" colspan="1">215.6 &#x000b1; 10.8</td><td align="center" rowspan="1" colspan="1">219.2 &#x000b1; 11.8</td><td align="center" rowspan="1" colspan="1">0.056&#x000a7;</td></tr><tr><td rowspan="1" colspan="1">p intra&#x02020;</td><td align="center" rowspan="1" colspan="1">0.089</td><td align="center" rowspan="1" colspan="1">0.070</td><td align="center" rowspan="1" colspan="1">0.100</td><td align="center" rowspan="1" colspan="1">0.554</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x00394;CT</td><td align="center" rowspan="1" colspan="1">30.0</td><td align="center" rowspan="1" colspan="1">15.3</td><td align="center" rowspan="1" colspan="1">8.2</td><td align="center" rowspan="1" colspan="1">6.1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">% &#x00394;CT</td><td align="center" rowspan="1" colspan="1">12.8</td><td align="center" rowspan="1" colspan="1">6.7</td><td align="center" rowspan="1" colspan="1">3.7</td><td align="center" rowspan="1" colspan="1">2.9</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td colspan="9" rowspan="1"><bold>HDL women</bold></td></tr><tr><td rowspan="1" colspan="1">Before</td><td align="center" rowspan="1" colspan="1">48.5 &#x000b1; 2.2</td><td align="center" rowspan="1" colspan="1">48.1 &#x000b1; 3.2</td><td align="center" rowspan="1" colspan="1">48.6 &#x000b1; 3.1</td><td align="center" rowspan="1" colspan="1">44.1 &#x000b1; 2.4</td><td align="center" rowspan="1" colspan="1">0.321&#x02021;</td><td rowspan="2" align="center" colspan="1">0.077</td><td rowspan="2" align="center" colspan="1">0.973</td><td rowspan="2" align="center" colspan="1">0.495</td></tr><tr><td rowspan="1" colspan="1">After</td><td align="center" rowspan="1" colspan="1">47.0 &#x000b1; 3.1</td><td align="center" rowspan="1" colspan="1">45.0 &#x000b1; 2.1</td><td align="center" rowspan="1" colspan="1">46.2 &#x000b1; 2.3</td><td align="center" rowspan="1" colspan="1">48.6 &#x000b1; 3.4</td><td align="center" rowspan="1" colspan="1">0.755&#x000a7;</td></tr><tr><td rowspan="1" colspan="1">p intra&#x02020;</td><td align="center" rowspan="1" colspan="1">0.507</td><td align="center" rowspan="1" colspan="1">0.348</td><td align="center" rowspan="1" colspan="1">0.157</td><td align="center" rowspan="1" colspan="1">0.074</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x00394;HDL women</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">3.1</td><td align="center" rowspan="1" colspan="1">2.4</td><td align="center" rowspan="1" colspan="1">4.5</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">% &#x00394;HDL women</td><td align="center" rowspan="1" colspan="1">3.1</td><td align="center" rowspan="1" colspan="1">6.4</td><td align="center" rowspan="1" colspan="1">4.9</td><td align="center" rowspan="1" colspan="1">10.2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td colspan="9" rowspan="1"><bold>HDL men</bold></td></tr><tr><td rowspan="1" colspan="1">Before</td><td align="center" rowspan="1" colspan="1">43.0 &#x000b1; 6.5</td><td align="center" rowspan="1" colspan="1">36.0 &#x000b1; 3.5</td><td align="center" rowspan="1" colspan="1">37.3 &#x000b1; 3.7</td><td align="center" rowspan="1" colspan="1">34.8 &#x000b1; 2.1</td><td align="center" rowspan="1" colspan="1">0.212&#x02021;</td><td rowspan="2" align="center" colspan="1">0.047</td><td rowspan="2" align="center" colspan="1">0.659</td><td rowspan="2" align="center" colspan="1">0.484</td></tr><tr><td rowspan="1" colspan="1">After</td><td align="center" rowspan="1" colspan="1">40.0 &#x000b1; 4.8</td><td align="center" rowspan="1" colspan="1">32.7 &#x000b1; 0.3</td><td align="center" rowspan="1" colspan="1">36.0 &#x000b1; 3.1</td><td align="center" rowspan="1" colspan="1">40.8 &#x000b1; 8.3</td><td align="center" rowspan="1" colspan="1">0.145&#x000a7;</td></tr><tr><td rowspan="1" colspan="1">p intra&#x02020;</td><td align="center" rowspan="1" colspan="1">0.431</td><td align="center" rowspan="1" colspan="1">0.477</td><td align="center" rowspan="1" colspan="1">0.921</td><td align="center" rowspan="1" colspan="1">0.021</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x00394;HDL men</td><td align="center" rowspan="1" colspan="1">3.0</td><td align="center" rowspan="1" colspan="1">3.3</td><td align="center" rowspan="1" colspan="1">1.3</td><td align="center" rowspan="1" colspan="1">6.0</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">% &#x00394;HDL men</td><td align="center" rowspan="1" colspan="1">7.0</td><td align="center" rowspan="1" colspan="1">9.2</td><td align="center" rowspan="1" colspan="1">3.5</td><td align="center" rowspan="1" colspan="1">17.2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn><p>//: time effect (before versus after); &#x000b6;: group effect; #: interaction
effect time versus group; &#x02021;: comparison among groups before the
intervention; &#x000a7;: comparison among groups after the intervention; &#x02020;:
comparisons before and after the intervention; &#x00394;: mean variation
(initial - initial). DIP: dietary intervention; DIPE: dietary
intervention + physical activity; DIS3: dietary intervention + omega 3
fatty acid supplementation; DIS3PE: dietary intervention + physical
activity + omega 3 fatty acid supplementation.</p></fn></table-wrap-foot></table-wrap><p>The differences in HDL-C levels observed before and after the intervention and
between groups were not significant for women, although the DIS3PE group exhibited a
mean increase of 10.2% at the end of the study (compared with that at baseline). The
remaining groups exhibited a decrease at the end of the intervention. There was a
significant difference in HDL-C levels among the men in terms of both the group
effect (p &#x0003e; 0.05) and interaction (p &#x0003e; 0.05). However, there was a significant
difference with regard to time (p &#x0003c; 0.05), indicating that after the
intervention, the mean HDL levels differed significantly among men, regardless of
the group. According to the estimated means, the DIS3PE group exhibited a
significant increase in HDL-C levels after the intervention (p &#x0003c; 0.05), whereas
the remaining groups exhibited an insignificant decrease in the mean levels after
the intervention (<xref ref-type="table" rid="t03">Table 3</xref>).</p><p>With regard to mean glucose levels, only time had a significant effect (p &#x0003c;
0.001), suggesting that, regardless of the group, there was a significant decrease
at the end of the intervention. Therefore, we believe that the treatments had a
similar effect with regard to this variable. The same was observed for the mean
values of SAP; only the effect of time was significant (p &#x02264; 0.001). This indicated
that, regardless of the group, the mean SAP values were lower after the intervention
than before the intervention (<xref ref-type="table" rid="t04">Table 4</xref>).</p><table-wrap id="t04" orientation="portrait" position="float"><label>Table 4</label><caption><p>Mean and standard deviations for glucose levels, systolic arterial pressure
(SAP), and abdominal circumference (AC) before and after the intervention
for each group</p></caption><table frame="hsides" rules="rows"><thead><tr><th rowspan="3" align="left" colspan="1"><bold>Variables</bold></th><th colspan="4" rowspan="1"><bold>Bivariate</bold></th><th colspan="4" rowspan="1"><bold>Multivariate</bold></th></tr><tr><th colspan="4" align="center" rowspan="1"><bold>Groups</bold></th><th rowspan="2" align="center" colspan="1"><bold>p between
groups</bold></th><th rowspan="2" align="center" colspan="1"><bold>p time
effect//</bold></th><th rowspan="2" align="center" colspan="1"><bold>p group
effect&#x000b6;</bold></th><th rowspan="2" align="center" colspan="1"><bold>p interaction
effect#</bold></th></tr><tr><th align="center" rowspan="1" colspan="1"><bold>DIP(n = 18)</bold></th><th align="center" rowspan="1" colspan="1"><bold>DIPE (n = 15)</bold></th><th align="center" rowspan="1" colspan="1"><bold>DIS3 (n = 20)</bold></th><th align="center" rowspan="1" colspan="1"><bold>DIS3PE (n = 17)</bold></th></tr></thead><tbody><tr><td colspan="9" rowspan="1"><bold>Glucose</bold></td></tr><tr><td rowspan="1" colspan="1">Before</td><td align="center" rowspan="1" colspan="1">95.1 &#x000b1; 8.9</td><td align="center" rowspan="1" colspan="1">112.8 &#x000b1; 9.7</td><td align="center" rowspan="1" colspan="1">111.7 &#x000b1; 8.4</td><td align="center" rowspan="1" colspan="1">110.1 &#x000b1; 9.1</td><td align="center" rowspan="1" colspan="1">0.087&#x02021;</td><td rowspan="2" align="center" colspan="1">0.002</td><td rowspan="2" align="center" colspan="1">0.385</td><td rowspan="2" align="center" colspan="1">0.562</td></tr><tr><td rowspan="1" colspan="1">After</td><td align="center" rowspan="1" colspan="1">90.6 &#x000b1; 4.3</td><td align="center" rowspan="1" colspan="1">95.1 &#x000b1; 4.7</td><td align="center" rowspan="1" colspan="1">100.1 &#x000b1; 4.1</td><td align="center" rowspan="1" colspan="1">101.7 &#x000b1; 4.4</td><td align="center" rowspan="1" colspan="1">0.112&#x000a7;</td></tr><tr><td rowspan="1" colspan="1">p intra&#x02020;</td><td align="center" rowspan="1" colspan="1">0.042</td><td align="center" rowspan="1" colspan="1">0.192</td><td align="center" rowspan="1" colspan="1">0.040</td><td align="center" rowspan="1" colspan="1">0.009</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x00394; glucose</td><td align="center" rowspan="1" colspan="1">4.5</td><td align="center" rowspan="1" colspan="1">17.7</td><td align="center" rowspan="1" colspan="1">11.6</td><td align="center" rowspan="1" colspan="1">8.4</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">% &#x00394;glucose</td><td align="center" rowspan="1" colspan="1">4.7</td><td align="center" rowspan="1" colspan="1">15.7</td><td align="center" rowspan="1" colspan="1">10.4</td><td align="center" rowspan="1" colspan="1">7.6</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td colspan="9" rowspan="1"><bold>SAP</bold></td></tr><tr><td rowspan="1" colspan="1">Before</td><td align="center" rowspan="1" colspan="1">134.4 &#x000b1; 3.8</td><td align="center" rowspan="1" colspan="1">131.1 &#x000b1; 4.2</td><td align="center" rowspan="1" colspan="1">130.2 &#x000b1; 3.6</td><td align="center" rowspan="1" colspan="1">131.6 &#x000b1; 3.9</td><td align="center" rowspan="1" colspan="1">0.667&#x02021;</td><td rowspan="2" align="center" colspan="1">0.001</td><td rowspan="2" align="center" colspan="1">0.702</td><td rowspan="2" align="center" colspan="1">0.935</td></tr><tr><td rowspan="1" colspan="1">After</td><td align="center" rowspan="1" colspan="1">127.0 &#x000b1; 2.9</td><td align="center" rowspan="1" colspan="1">122.4 &#x000b1; 3.2</td><td align="center" rowspan="1" colspan="1">123.4 &#x000b1; 2.8</td><td align="center" rowspan="1" colspan="1">126.7 &#x000b1; 3.0</td><td align="center" rowspan="1" colspan="1">0.702&#x000a7;</td></tr><tr><td rowspan="1" colspan="1">p intra&#x02020;</td><td align="center" rowspan="1" colspan="1">0.075</td><td align="center" rowspan="1" colspan="1">0.070</td><td align="center" rowspan="1" colspan="1">0.091</td><td align="center" rowspan="1" colspan="1">0.281</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x00394;SAP</td><td align="center" rowspan="1" colspan="1">7.4</td><td align="center" rowspan="1" colspan="1">8.7</td><td align="center" rowspan="1" colspan="1">6.8</td><td align="center" rowspan="1" colspan="1">4.9</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">% &#x00394;SAP</td><td align="center" rowspan="1" colspan="1">5.5</td><td align="center" rowspan="1" colspan="1">6.6</td><td align="center" rowspan="1" colspan="1">5.2</td><td align="center" rowspan="1" colspan="1">3.7</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td colspan="9" rowspan="1"><bold>AC women</bold></td></tr><tr><td rowspan="1" colspan="1">Before</td><td align="center" rowspan="1" colspan="1">102.2 &#x000b1; 1.5</td><td align="center" rowspan="1" colspan="1">101.7 &#x000b1; 2.5</td><td align="center" rowspan="1" colspan="1">108.1 &#x000b1; 2.6</td><td align="center" rowspan="1" colspan="1">107.2 &#x000b1; 1.9</td><td align="center" rowspan="1" colspan="1">0.357&#x02021;</td><td rowspan="2" align="center" colspan="1">&#x0003c;0.001</td><td rowspan="2" align="center" colspan="1">0.233</td><td rowspan="2" align="center" colspan="1">0.017</td></tr><tr><td rowspan="1" colspan="1">After</td><td align="center" rowspan="1" colspan="1">100.1 &#x000b1; 1.7</td><td align="center" rowspan="1" colspan="1">97.1 &#x000b1; 2.8</td><td align="center" rowspan="1" colspan="1">103.2 &#x000b1; 3.0</td><td align="center" rowspan="1" colspan="1">99.8 &#x000b1; 2.3</td><td align="center" rowspan="1" colspan="1">0.102&#x000a7;</td></tr><tr><td rowspan="1" colspan="1">p intra&#x02020;</td><td align="center" rowspan="1" colspan="1">0.016</td><td align="center" rowspan="1" colspan="1">0.005</td><td align="center" rowspan="1" colspan="1">0.004</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x00394;CA women</td><td align="center" rowspan="1" colspan="1">2.1</td><td align="center" rowspan="1" colspan="1">4.6</td><td align="center" rowspan="1" colspan="1">4.9</td><td align="center" rowspan="1" colspan="1">7.4</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">% &#x00394;AC women</td><td align="center" rowspan="1" colspan="1">2.1</td><td align="center" rowspan="1" colspan="1">4.5</td><td align="center" rowspan="1" colspan="1">4.5</td><td align="center" rowspan="1" colspan="1">6.9</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td colspan="9" rowspan="1"><bold>AC men</bold></td></tr><tr><td rowspan="1" colspan="1">Before</td><td align="center" rowspan="1" colspan="1">110.6 &#x000b1; 5.4</td><td align="center" rowspan="1" colspan="1">104.3 &#x000b1; 2.2</td><td align="center" rowspan="1" colspan="1">113.6 &#x000b1; 2.6</td><td align="center" rowspan="1" colspan="1">109.7 &#x000b1; 1.9</td><td align="center" rowspan="1" colspan="1">0.202&#x02021;</td><td rowspan="2" align="center" colspan="1">&#x0003c;0.001</td><td rowspan="2" align="center" colspan="1">0.413</td><td rowspan="2" align="center" colspan="1">0.974</td></tr><tr><td rowspan="1" colspan="1">After</td><td align="center" rowspan="1" colspan="1">103.2 &#x000b1; 6.1</td><td align="center" rowspan="1" colspan="1">98.7 &#x000b1; 3.8</td><td align="center" rowspan="1" colspan="1">107.1 &#x000b1; 9.7</td><td align="center" rowspan="1" colspan="1">103.2 &#x000b1; 1.8</td><td align="center" rowspan="1" colspan="1">0.285&#x000a7;</td></tr><tr><td rowspan="1" colspan="1">p intra&#x02020;</td><td align="center" rowspan="1" colspan="1">0.068</td><td align="center" rowspan="1" colspan="1">0.196</td><td align="center" rowspan="1" colspan="1">0.020</td><td align="center" rowspan="1" colspan="1">0.005</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x00394;AC men</td><td align="center" rowspan="1" colspan="1">7.4</td><td align="center" rowspan="1" colspan="1">5.6</td><td align="center" rowspan="1" colspan="1">6.5</td><td align="center" rowspan="1" colspan="1">6.5</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">% &#x00394;AC men</td><td align="center" rowspan="1" colspan="1">6.7</td><td align="center" rowspan="1" colspan="1">5.4</td><td align="center" rowspan="1" colspan="1">5.7</td><td align="center" rowspan="1" colspan="1">5.9</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn><p>//: time effect (before versus after); &#x000b6; group effect; #: interaction
effect time versus group; &#x02021;: comparison among groups before the
intervention; &#x000a7;: comparison among groups after the intervention; &#x02020;:
comparisons before and after the intervention; &#x00394;: mean variation
(initial - initial). DIP: dietary intervention; DIPE: dietary
intervention + physical activity; DIS3: dietary intervention + omega 3
fatty acid supplementation; DIS3PE: dietary intervention + physical
activity + omega 3 fatty acid supplementation</p></fn></table-wrap-foot></table-wrap><p>A significant difference in AC with time was observed for women, indicating a
significant decrease in the mean AC after the intervention (p &#x0003c; 0.001). At the
end of treatment, all groups exhibited a lower mean AC. According to the data
collected before and after the intervention, the greatest decrease occurred in the
DIS3PE group (6.9%), which showed a significant effect (p &#x0003c; 0. 05). This
suggested that the decrease in the mean AC was greater in this group than in the DIP
(p &#x0003c; 0.05), DIPE (p &#x0003c; 0.05), and DIS3 (p &#x0003c; 0.05) groups; there were no
differences between the means in the latter groups.</p><p>In men, only time had a significant effect on AC (p &#x0003c; 0.001), which demonstrated a
significant decrease after the intervention, regardless of the group (<xref ref-type="table" rid="t04">Table 4</xref>).</p></sec><sec sec-type="discussion"><title>Discussion</title><p>In this randomized clinical trial, score evaluation showed that 25.7% patients were
at a high risk of developing coronary events within 10 years. After the intervention
proposed in this study, the prevalence decreased to 11.4%, indicating that lifestyle
modification contributes to a decrease in cardiovascular risk. Therefore, the
present study had a positive impact and reinforced the importance of lifestyle
modification for the prevention and treatment of cardiovascular diseases. </p><p>All interventions proposed in this study led to a decrease in the assessed
cardiovascular risk score by decreasing the risk of coronary events occurring within
10 years. Wister et al<sup><xref rid="r07" ref-type="bibr">7</xref></sup>
investigated the effects of lifestyle modification counseling via telephone and
observed a decrease in cardiovascular risk using this score in adults. </p><p>According to the concept of VA proposed in Framingham's study, which aims to adjust
the patients' age to their atherosclerotic state, this study found that the mean VA
was higher than the chronological age in all groups. Similar data were obtained in a
study conducted in the state of Rio de Janeiro, wherein the researchers observed a
mean age of 61.0 &#x000b1; 20.0 years, which was higher than the patients' chronological age
(56.0 &#x000b1; 10.0 years)<sup><xref rid="r18" ref-type="bibr">18</xref></sup>.</p><p>Inadequate nutrition, physical inactivity, and genetic predisposition are some of the
main factors that contribute to the occurrence of MS<sup><xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r20" ref-type="bibr">20</xref></sup>. The aim
of studying individuals with MS is to prevent cardiovascular events. A cohort that
aimed to determine the incidence of MS in adult individuals without diabetes showed
that AC was the best predictor of MS<sup><xref rid="r21" ref-type="bibr">21</xref></sup>. This is important data because the main metabolic alterations
associated with abdominal obesity are dyslipidemia and insulin resistance. In the
present study, a significant decrease in mean AC was observed after the intervention
in women (p &#x0003c; 0.001); the greatest decrease occurred in the DIS3PE group (6.9%),
in which there was a significant effect (p &#x0003c; 0.05). In men, only time had a
significant effect (p &#x0003c; 0.001), with a significant decrease in AC being observed
after the evaluation, regardless of group. </p><p>All the interventions had an effect on the decrease in blood glucose and SAP, as
demonstrated by other studies in which diet quality improvement promoted a decrease
in blood glucose<sup><xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r23" ref-type="bibr">23</xref></sup> levels and SAP<sup><xref rid="r24" ref-type="bibr">24</xref>,<xref rid="r25" ref-type="bibr">25</xref></sup>. Prevention and
treatment of arterial hypertension through health promotion present important
clinical implications because they can decrease or even eliminate the need for
antihypertensive drugs, thereby avoiding the adverse effects of pharmacological
treatment and decreasing the cost of treatment for the patients and health
institutions.</p><p>The variations in TC with time were significant; however, after the intervention, we
observed an increase in the TC and HDL-C levels in both men and women in the DIS3PE
group. This increase in TC may be associated with the increase in HDL-C levels in
this group. Physical exercise promotes the increase in HDL-C levels; however, this
occurs with simultaneous weight loss<sup><xref rid="r26" ref-type="bibr">26</xref></sup>. There is evidence that the omega 3 fatty acids
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are derived from
fish oil, promote the modulation of lipoprotein levels and endothelium
function<sup><xref rid="r27" ref-type="bibr">27</xref>,<xref rid="r28" ref-type="bibr">28</xref></sup>. The increase in TC and HDL-C levels may be
associated with the intervention received by the DIS3PE group, with this group
standing out in terms of lipid profile treatment.</p><p>Our results suggest that the dietary counseling given to all groups may be considered
to be a key tool for the overall treatment of patients with MS. The positive results
of this study in regard to the metabolic and cardiovascular parameters confirm that
dietary intervention is therapeutically relevant. The various interventions
conducted in the 4 groups proved to be effective, suggesting that lifestyle
modifications are key to the decrease in the risk of cardiovascular events and are
effective in the treatment of MS. The study focused on eating habits and physical
activities, two essential axes of the first-line therapy for improving modifiable
risk factors for cardiovascular diseases, and it covered most modifiable risk
factors indicated by the WHO<sup><xref rid="r29" ref-type="bibr">29</xref></sup>.
Therefore, intervention programs that promote lifestyle changes should be encouraged
to improve the quality of life of the population at risk. </p><p>It is worth noting that the size of the sample was a limitation of this study. It was
difficult to confirm the results of the interaction effect (group and time repeated
measurements analysis) because the differences were pronounced but not significant.
Moreover, the number of patients was not sufficient to demonstrate other changes
that may have occurred during the intervention period.</p><p>The small number of studies on these scores and clinical interventions
(pharmacological and nonpharmacological) makes this study a preliminary study that
describes the potential effects of lifestyle modification on the decrease in
cardiovascular risk using the Framingham risk score. Further studies with larger
samples are necessary to better understand the effects of lifestyle modification
interventions on the abovementioned score and to conduct stratified analyses.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>In this study, all groups exhibited a similar pattern of behavior during the proposed
intervention and did not show any intergroup differences. There was a decrease in
the cardiovascular risk score, vascular age, and risk factors included in the
calculation of the score. Therefore, we conclude that lifestyle modification by
itself is a key tool for the overall treatment of patients with metabolic
syndrome.</p></sec></body><back><fn-group><fn fn-type="con"><p><bold>Author contributions</bold></p><p>Conception and design of the research and Statistical analysis: Soares TS,
Gustavo AS, Macagnan FE, Feoli AMP; Acquisition of data: Soares TS, Piovesan CH,
Gustavo AS, Macagnan FE, Feoli AMP; Analysis and interpretation of the data:
Soares TS, Piovesan CH, Gustavo AS, Macagnan FE, Feoli AMP; Obtaining financing:
Gustavo AS, Macagnan FE, Bodanese LC, Feoli AMP; Writing of the manuscript:
Soares TS, Piovesan CH, Gustavo AS, Macagnan FE, Bodanese LC, Feoli AMP;
Critical revision of the manuscript for intellectual content: Soares TS,
Piovesan CH, Gustavo AS, Macagnan FE, Bodanese LC, Feoli AMP.</p></fn><fn fn-type="conflict"><p><bold>Potential Conflict of Interest</bold></p><p>No potential conflict of interest relevant to this article was reported.</p></fn><fn fn-type="financial-disclosure"><p><bold>Sources of Funding</bold></p><p>This study was funded by CNPq and FAPERGS.</p></fn><fn fn-type="other"><p><bold>Study Association</bold></p><p>This article is part of the thesis of master submitted by Thays Soliman Soares,
from Pontif&#x000ed;cia Universidade Cat&#x000f3;lica do Rio Grande do Sul.</p></fn></fn-group><ref-list><title>References</title><ref id="r01"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand&#x000e3;o</surname><given-names>AP</given-names></name><name><surname>Brand&#x000e3;o</surname><given-names>AA</given-names></name><name><surname>Nogueira</surname><given-names>AR</given-names></name><name><surname>Suplicy</surname><given-names>H</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>JI</given-names></name><name><surname>Oliveira</surname><given-names>JE</given-names></name><etal>et al</etal><collab>Sociedade Brasileira de Cardiologia</collab></person-group><article-title xml:lang="pt">I Diretriz brasileira de diagn&#x000f3;stico e tratamento
da s&#x000ed;ndrome metab&#x000f3;lica</article-title><source>Arq Bras Cardiol</source><year>2005</year><volume>84</volume><issue>supl 1</issue><fpage>1</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">16127596</pub-id></element-citation></ref><ref id="r02"><label>2</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>World Health Organization. (WHO)</collab></person-group><source>Noncommunicable diseases country profiles, 2011</source><date-in-citation content-type="access-date">Cited 2012 Nov
13</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/nmh/countries/bra_en.pdf">http://www.who.int/nmh/countries/bra_en.pdf</ext-link></comment></element-citation></ref><ref id="r03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Andrea</surname><given-names>F</given-names></name><name><surname>Giugliano</surname><given-names>D</given-names></name></person-group><article-title>Effect of a mediterranean-style diet on endothelial dysfunction
and markers of vascular inflammation in the metabolic syndrome: a randomized
trial</article-title><source>JAMA</source><year>2004</year><volume>292</volume><issue>12</issue><fpage>1440</fpage><lpage>1446</lpage><pub-id pub-id-type="pmid">15383514</pub-id></element-citation></ref><ref id="r04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villareal</surname><given-names>DT</given-names></name><name><surname>Miller</surname><given-names>BV</given-names></name><name><surname>Banks</surname><given-names>M</given-names></name><name><surname>Fontana</surname><given-names>L</given-names></name><name><surname>Sinacore</surname><given-names>DR</given-names></name><name><surname>Klein</surname><given-names>S</given-names></name></person-group><article-title>Effect of lifestyle intervention on metabolic coronary heart
disease risk factors in obese older adults</article-title><source>Am J Clin Nutr</source><year>2006</year><volume>84</volume><issue>6</issue><fpage>1317</fpage><lpage>1323</lpage><pub-id pub-id-type="pmid">17158411</pub-id></element-citation></ref><ref id="r05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calder</surname><given-names>PC</given-names></name><name><surname>Ahluwalia</surname><given-names>N</given-names></name><name><surname>Brouns</surname><given-names>F</given-names></name><name><surname>Buetler</surname><given-names>T</given-names></name><name><surname>Clement</surname><given-names>K</given-names></name><name><surname>Cunningham</surname><given-names>K</given-names></name><etal>et al</etal></person-group><article-title>Dietary factors and low-grade inflammation in relation to
overweight and obesity</article-title><source>Br J Nutr</source><year>2011</year><volume>106</volume><issue>Suppl 3</issue><fpage>S5</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">22133051</pub-id></element-citation></ref><ref id="r06"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaoka</surname><given-names>K</given-names></name><name><surname>Tango</surname><given-names>T</given-names></name></person-group><article-title>Effects of lifestyle modification on metabolic syndrome: a
systematic review and meta-analysis</article-title><source>BMC Med</source><year>2012</year><volume>10</volume><fpage>138</fpage><pub-id pub-id-type="pmid">23151238</pub-id></element-citation></ref><ref id="r07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wister</surname><given-names>A</given-names></name><name><surname>Loewen</surname><given-names>N</given-names></name><name><surname>Kennedy-Symonds</surname><given-names>H</given-names></name><name><surname>McGowan</surname><given-names>B</given-names></name><name><surname>McCoy</surname><given-names>B</given-names></name><name><surname>Singer</surname><given-names>J</given-names></name></person-group><article-title>One-year follow-up of a therapeutic lifestyle intervention
targeting cardiovascular disease risk</article-title><source>CMAJ</source><year>2007</year><volume>177</volume><issue>8</issue><fpage>859</fpage><lpage>865</lpage><pub-id pub-id-type="pmid">17923653</pub-id></element-citation></ref><ref id="r08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000e1;rquez-Celedonio</surname><given-names>FG</given-names></name><name><surname>T&#x000e9;xon-Fern&#x000e1;ndez</surname><given-names>O</given-names></name><name><surname>Ch&#x000e1;vez-Negrete</surname><given-names>A</given-names></name><name><surname>Hern&#x000e1;ndez-L&#x000f3;pez</surname><given-names>S</given-names></name><name><surname>Mar&#x000ed;n-Rend&#x000f3;n</surname><given-names>S</given-names></name><name><surname>Berl&#x000ed;n-Lascurain</surname><given-names>S</given-names></name></person-group><article-title>Clinical effect of lifestyle modification on cardiovascular risk
in prehypertensives: PREHIPER I Study</article-title><source>Rev Esp Cardiol</source><year>2009</year><volume>62</volume><issue>1</issue><fpage>86</fpage><lpage>90</lpage></element-citation></ref><ref id="r09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arsenault</surname><given-names>BJ</given-names></name><name><surname>Rana</surname><given-names>JS</given-names></name><name><surname>Lemieux</surname><given-names>I</given-names></name><name><surname>Despr&#x000e9;s</surname><given-names>JP</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Kastelein</surname><given-names>JJ</given-names></name><etal>et al</etal></person-group><article-title>Physical activity, the Framingham risk score and risk of coronary
heart disease in men and women of the EPIC-Norfolk study</article-title><source>Atherosclerosis</source><year>2010</year><volume>209</volume><issue>1</issue><fpage>261</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">19772963</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Minist&#x000e9;rio da Sa&#x000fa;de</collab><collab>Secretaria de Aten&#x000e7;&#x000e3;o &#x000e0; Sa&#x000fa;de</collab><collab>Departamento de Aten&#x000e7;&#x000e3;o B&#x000e1;sica</collab></person-group><source xml:lang="pt">Preven&#x000e7;&#x000e3;o cl&#x000ed;nica de doen&#x000e7;a cardiovascular,
cerebrovascular e renal cr&#x000f4;nica</source><publisher-loc>Bras&#x000ed;lia</publisher-loc><year>2006</year><series>Cole&#x000e7;&#x000e3;o Cadernos de Aten&#x000e7;&#x000e3;o B&#x000e1;sica, 14. S&#x000e9;rie A</series></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Agostino</surname><given-names>RB Sr</given-names></name><name><surname>Vasan</surname><given-names>RS</given-names></name><name><surname>Pencina</surname><given-names>MJ</given-names></name><name><surname>Wolf</surname><given-names>PA</given-names></name><name><surname>Cobain</surname><given-names>M</given-names></name><name><surname>Massaro</surname><given-names>JM</given-names></name><etal>et al</etal></person-group><article-title>General cardiovascular risk profile for use in primary care: the
Framingham Heart Study</article-title><source>Circulation</source><year>2008</year><volume>117</volume><issue>6</issue><fpage>743</fpage><lpage>753</lpage><pub-id pub-id-type="pmid">18212285</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuende</surname><given-names>JI</given-names></name><name><surname>Cuende</surname><given-names>N</given-names></name><name><surname>Calaveras-Lagartos</surname><given-names>J</given-names></name></person-group><article-title>How to calculate vascular age with the SCORE project scales: a
new method of cardiovascular risk evaluation</article-title><source>Eur Heart J</source><year>2010</year><volume>31</volume><issue>19</issue><fpage>2351</fpage><lpage>2358</lpage><pub-id pub-id-type="pmid">20584778</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>National Cholesterol Education Program</collab></person-group><source>Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults: Executive Summary of the Third Report of the National
Cholesterol Education Program (NCEP)</source><publisher-name>National Heart, Lung, and Blood Institute. National Institutes
of Health. NIH Publication</publisher-name><month>9</month><year>2002</year><fpage>02</fpage><lpage>5215</lpage></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedewald</surname><given-names>WT</given-names></name><name><surname>Levy</surname><given-names>RI</given-names></name><name><surname>Fredrickson</surname><given-names>DS</given-names></name></person-group><article-title>Estimation of the concentration of low-density lipoprotein
cholesterol in plasma, without use of the preparative
ultracentrifuge</article-title><source>Clin Chem</source><year>1972</year><volume>18</volume><issue>6</issue><fpage>499</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">4337382</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lohman</surname><given-names>TG</given-names></name><name><surname>Roche</surname><given-names>AF</given-names></name><name><surname>Martorell</surname><given-names>R</given-names></name></person-group><source>Anthropometric standardization reference manual</source><publisher-loc>Champaign (IL)</publisher-loc><publisher-name>Human Kinetics Books</publisher-name><year>1988</year></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Institute of Medicine</collab></person-group><source>Dietary reference intakes: applications in dietary assessment</source><publisher-loc>Washington (DC)</publisher-loc><year>2000</year></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>The Framingham Heart Study</collab></person-group><source>A project of tha National Heart, Lung and Blood Institute and Boston
University</source><date-in-citation content-type="access-date">Cited 2011 Ago 2</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.framinghamheartstudy.org/risk/gencardio.html">http://www.framinghamheartstudy.org/risk/gencardio.html</ext-link></comment></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Deus</surname><given-names>FC</given-names></name></person-group><source xml:lang="pt">Associa&#x000e7;&#x000e3;o entre o escore de c&#x000e1;lcio coronariano e testes
funcionais n&#x000e3;o invasivos em pacientes de baixo risco e risco intermedi&#x000e1;rio
pelo escore de Framingham. [Disserta&#x000e7;&#x000e3;o]</source><publisher-loc>Rio de Janeiro</publisher-loc><publisher-name>Universidade Federal do Rio de Janeiro</publisher-name><year>2009</year></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiesa</surname><given-names>H</given-names></name><name><surname>Moresco</surname><given-names>RN</given-names></name><name><surname>de Bem</surname><given-names>AF</given-names></name></person-group><article-title xml:lang="pt">Avalia&#x000e7;&#x000e3;o do risco, conforme escores de risco de
Framingham, em pacientes ambulatoriais de salvador do Sul, S&#x000e3;o Pedro da
Serra e Bar&#x000e3;o (RS)</article-title><source>Sa&#x000fa;de, Santa Maria</source><year>2007</year><volume>33</volume><issue>1</issue><fpage>4</fpage><lpage>10</lpage></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakka</surname><given-names>TA</given-names></name><name><surname>Laaksonen</surname><given-names>DE</given-names></name><name><surname>Lakka</surname><given-names>HM</given-names></name><name><surname>M&#x000e4;nnikko</surname><given-names>N</given-names></name><name><surname>Niskanenn</surname><given-names>LK</given-names></name><name><surname>Rauramaa</surname><given-names>R</given-names></name><etal>et al</etal></person-group><article-title>Sedentary lifestyle, poor cardiorrespiratory fitness, and
metabolic syndrome</article-title><source>Med Sci Sports Exerc</source><year>2003</year><volume>35</volume><issue>8</issue><fpage>1279</fpage><lpage>1286</lpage><pub-id pub-id-type="pmid">12900679</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palaniappan</surname><given-names>L</given-names></name><name><surname>Carnethon</surname><given-names>MR</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Hanley</surname><given-names>AJ</given-names></name><name><surname>Fortmann</surname><given-names>SP</given-names></name><name><surname>Haffner</surname><given-names>SM</given-names></name><etal>et al</etal></person-group><article-title>Predictors of the incident metabolic syndrome in adults: the
Insulin Resistance Atherosclerosis Study</article-title><source>Diabetes Care</source><year>2004</year><volume>27</volume><issue>3</issue><fpage>788</fpage><lpage>793</lpage><pub-id pub-id-type="pmid">14988303</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giacco</surname><given-names>RM</given-names></name><name><surname>Parillo</surname><given-names>M</given-names></name><name><surname>Rivellese</surname><given-names>AA</given-names></name><name><surname>Lasorella</surname><given-names>G</given-names></name><name><surname>Giacco</surname><given-names>A</given-names></name><name><surname>D'Episcopo</surname><given-names>L</given-names></name><etal>et al</etal></person-group><article-title xml:lang="pt">Longo prazo do tratamento diet&#x000e9;tico com aumento da
quantidade de ricos em fibras, com baixo &#x000ed;ndice glic&#x000ea;mico alimentos
naturais, melhora o controle da glicose no sangue</article-title><source>Diabetes Care</source><year>2000</year><volume>23</volume><issue>10</issue><fpage>1461</fpage><lpage>1466</lpage><pub-id pub-id-type="pmid">11023137</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geraldo</surname><given-names>JM</given-names></name><name><surname>Alfenas</surname><given-names>RC</given-names></name><name><surname>Alves</surname><given-names>RD</given-names></name><name><surname>Salles</surname><given-names>VF</given-names></name><name><surname>Queiroz</surname><given-names>VM</given-names></name><name><surname>Bitencourt</surname><given-names>MC</given-names></name></person-group><article-title xml:lang="pt">Interven&#x000e7;&#x000e3;o nutricional sobre medidas
antropom&#x000e9;tricas e glicemia de jejum de pacientes diab&#x000e9;ticos</article-title><source>Rev Nutr Campinas</source><year>2008</year><volume>21</volume><issue>3</issue><fpage>329</fpage><lpage>340</lpage></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>KM</given-names></name><name><surname>Westborg</surname><given-names>CJ</given-names></name><name><surname>Eliasson</surname><given-names>MC</given-names></name></person-group><article-title>A randomized trial of lifestyle intervention in primary
healthcare for the modification of cardiovascular risk factors: the Bj&#x000f6;rkn&#x000e4;s
study</article-title><source>Scand J Public Health</source><year>2006</year><volume>34</volume><issue>5</issue><fpage>453</fpage><lpage>461</lpage><pub-id pub-id-type="pmid">16990155</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bo</surname><given-names>S</given-names></name><name><surname>Ciccone</surname><given-names>G</given-names></name><name><surname>Baldi</surname><given-names>C</given-names></name><name><surname>Benini</surname><given-names>L</given-names></name><name><surname>Dusio</surname><given-names>F</given-names></name><name><surname>Forastiere</surname><given-names>G</given-names></name><etal>et al</etal></person-group><article-title>Effectiveness of a lifestyle intervention on metabolic syndrome:
a randomized controlled trial</article-title><source>J Gen Intern Med</source><year>2007</year><volume>22</volume><issue>12</issue><fpage>1695</fpage><lpage>1703</lpage><pub-id pub-id-type="pmid">17922167</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonong</surname><given-names>T</given-names></name><name><surname>Toth</surname><given-names>MJ</given-names></name><name><surname>Ades</surname><given-names>PA</given-names></name><name><surname>Katzel</surname><given-names>LI</given-names></name><name><surname>Calles-Escandon</surname><given-names>J</given-names></name><name><surname>Poehlman</surname><given-names>ET</given-names></name></person-group><article-title>Relationship between physical activity and HDL-cholesterol in
healthy older men and women: a cross-sectional and exercise intervention
study</article-title><source>Atherosclerosis</source><year>1996</year><volume>127</volume><issue>2</issue><fpage>177</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">9125307</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massaro</surname><given-names>M</given-names></name><name><surname>Scoditti</surname><given-names>E</given-names></name><name><surname>Carluccio</surname><given-names>MA</given-names></name><name><surname>De Caterina</surname><given-names>R</given-names></name></person-group><article-title>Nutraceuticals and prevention of atherosclerosis: focus on
omega-3 polyunsaturated fatty acids and Mediterranean diet
polyphenols</article-title><source>Cardiovasc Ther</source><year>2010</year><volume>28</volume><issue>4</issue><fpage>e13</fpage><lpage>e19</lpage><pub-id pub-id-type="pmid">20633019</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laugerette</surname><given-names>F</given-names></name><name><surname>Vors</surname><given-names>C</given-names></name><name><surname>Peretti</surname><given-names>N</given-names></name><name><surname>Michalski</surname><given-names>MC</given-names></name></person-group><article-title>Complex links between dietary lipids, endogenous endotoxins and
metabolic inflammation</article-title><source>Biochimie</source><year>2011</year><volume>93</volume><issue>1</issue><fpage>39</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">20433893</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>JJ</given-names></name></person-group><article-title>The world health report 2002 - reducing risks, promoting healthy
life</article-title><source>Educ Health (Abingdon)</source><year>2003</year><volume>16</volume><issue>2</issue><fpage>230</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">14741909</pub-id></element-citation></ref></ref-list></back></article>